Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer

Abstract Purpose During breast cancer surgery, the use of dyes such as indigo carmine, methylene blue, or indocyanine green (ICG) for targeting axillary lymph nodes (ALNs) under ultrasound guidance can result in rapid diffusion, complicated tissue differentiation, and disruption of staining. LuminoM...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeeyeon Lee, Byeongju Kang, Jin Hyang Jung, Hye Jung Kim, Won Hwa Kim, Jung Dug Yang, Joon Seok Lee, Yee Soo Chae, Soo Jung Lee, In Hee Lee, Ji-Young Park, Nora Jee-Young Park, Ho Yong Park
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13175-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559381374664704
author Jeeyeon Lee
Byeongju Kang
Jin Hyang Jung
Hye Jung Kim
Won Hwa Kim
Jung Dug Yang
Joon Seok Lee
Yee Soo Chae
Soo Jung Lee
In Hee Lee
Ji-Young Park
Nora Jee-Young Park
Ho Yong Park
author_facet Jeeyeon Lee
Byeongju Kang
Jin Hyang Jung
Hye Jung Kim
Won Hwa Kim
Jung Dug Yang
Joon Seok Lee
Yee Soo Chae
Soo Jung Lee
In Hee Lee
Ji-Young Park
Nora Jee-Young Park
Ho Yong Park
author_sort Jeeyeon Lee
collection DOAJ
description Abstract Purpose During breast cancer surgery, the use of dyes such as indigo carmine, methylene blue, or indocyanine green (ICG) for targeting axillary lymph nodes (ALNs) under ultrasound guidance can result in rapid diffusion, complicated tissue differentiation, and disruption of staining. LuminoMark™, a novel ICG-hyaluronic acid mixture, can provide real-time visualization and minimize dye spread, thereby ensuring a clear surgical field. The aim of our study was to evaluate the efficacy of LuminoMark™ for targeting ALNs in patients with breast cancer. Methods A total of 13 patients with breast cancer (mean age 56.5 years; 92.3% female) and suspicious ALNs underwent targeted axillary surgery (TAS) with activated charcoal and LuminoMark™ injected into the LNs in the surgical field. The clinicopathological variables of the patients and diagnostic performance were assessed. The LNs injected with LuminoMark™ were examined for consistency with sentinel LNs (SLNs) and non-SLNs, as well as with charcoal-tattooed LNs. Results The identification of SLNs took approximately 15.6 min from the start of skin incision, and it required 25.6 and 17.7 min, for charcoal-tattooed and LuminoMarkTM-illuminated LNs, respectively. The identification rate was 92.3% with charcoal and 100% with LuminoMark™. The concordance rate between LuminoMark™ illumination and SLNs was higher than that between charcoal tattooing and SLNs. The concordance rate between the two methods was 76.9% (n = 10). Three months after surgery, the charcoal tattoo remained visible on the skin; however, LuminoMark™ was not visible. Conclusion Although both methods demonstrated high detection rates, the rate was higher using LuminoMark™. As LuminoMark™ was administered directly into LNs, this improved the accuracy of identifying LNs.
format Article
id doaj-art-a210a9bc7e5e48078307d10fafdcc710
institution Kabale University
issn 1471-2407
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-a210a9bc7e5e48078307d10fafdcc7102025-01-05T12:33:10ZengBMCBMC Cancer1471-24072024-12-0124111010.1186/s12885-024-13175-9Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancerJeeyeon Lee0Byeongju Kang1Jin Hyang Jung2Hye Jung Kim3Won Hwa Kim4Jung Dug Yang5Joon Seok Lee6Yee Soo Chae7Soo Jung Lee8In Hee Lee9Ji-Young Park10Nora Jee-Young Park11Ho Yong Park12Department of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Radiology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Radiology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Plastic Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Plastic Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Hematology and Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Hematology and Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Hematology and Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalDepartment of Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok HospitalAbstract Purpose During breast cancer surgery, the use of dyes such as indigo carmine, methylene blue, or indocyanine green (ICG) for targeting axillary lymph nodes (ALNs) under ultrasound guidance can result in rapid diffusion, complicated tissue differentiation, and disruption of staining. LuminoMark™, a novel ICG-hyaluronic acid mixture, can provide real-time visualization and minimize dye spread, thereby ensuring a clear surgical field. The aim of our study was to evaluate the efficacy of LuminoMark™ for targeting ALNs in patients with breast cancer. Methods A total of 13 patients with breast cancer (mean age 56.5 years; 92.3% female) and suspicious ALNs underwent targeted axillary surgery (TAS) with activated charcoal and LuminoMark™ injected into the LNs in the surgical field. The clinicopathological variables of the patients and diagnostic performance were assessed. The LNs injected with LuminoMark™ were examined for consistency with sentinel LNs (SLNs) and non-SLNs, as well as with charcoal-tattooed LNs. Results The identification of SLNs took approximately 15.6 min from the start of skin incision, and it required 25.6 and 17.7 min, for charcoal-tattooed and LuminoMarkTM-illuminated LNs, respectively. The identification rate was 92.3% with charcoal and 100% with LuminoMark™. The concordance rate between LuminoMark™ illumination and SLNs was higher than that between charcoal tattooing and SLNs. The concordance rate between the two methods was 76.9% (n = 10). Three months after surgery, the charcoal tattoo remained visible on the skin; however, LuminoMark™ was not visible. Conclusion Although both methods demonstrated high detection rates, the rate was higher using LuminoMark™. As LuminoMark™ was administered directly into LNs, this improved the accuracy of identifying LNs.https://doi.org/10.1186/s12885-024-13175-9Breast neoplasmSentinel lymph nodeIndocyanine greenCharcoal
spellingShingle Jeeyeon Lee
Byeongju Kang
Jin Hyang Jung
Hye Jung Kim
Won Hwa Kim
Jung Dug Yang
Joon Seok Lee
Yee Soo Chae
Soo Jung Lee
In Hee Lee
Ji-Young Park
Nora Jee-Young Park
Ho Yong Park
Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
BMC Cancer
Breast neoplasm
Sentinel lymph node
Indocyanine green
Charcoal
title Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
title_full Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
title_fullStr Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
title_full_unstemmed Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
title_short Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
title_sort feasibility of an indocyanine green hyaluronic acid mixture luminomark™ for targeting suspicious axillary lymph nodes in patients with breast cancer
topic Breast neoplasm
Sentinel lymph node
Indocyanine green
Charcoal
url https://doi.org/10.1186/s12885-024-13175-9
work_keys_str_mv AT jeeyeonlee feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT byeongjukang feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT jinhyangjung feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT hyejungkim feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT wonhwakim feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT jungdugyang feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT joonseoklee feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT yeesoochae feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT soojunglee feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT inheelee feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT jiyoungpark feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT norajeeyoungpark feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer
AT hoyongpark feasibilityofanindocyaninegreenhyaluronicacidmixtureluminomarkfortargetingsuspiciousaxillarylymphnodesinpatientswithbreastcancer